产品说明书

Dinoprost tromethamine salt

Print
Chemical Structure| 38562-01-5 同义名 : 地诺前列素 ;Prostaglandin F2α THAM;Prostaglandin F2α tromethamine salt;Prostamate;U 14585;PGF2α;Dinoprost;Prostaglandin F2α (tromethamine salt);Dinoprost Trometamol;Prostin F2 alpha;Zinoprost;PGF2-alpha tham;Dinolytic;Dinoprost tromethamine;PGF2α THAM
CAS号 : 38562-01-5
货号 : A385706
分子式 : C24H45NO8
纯度 : 98%
分子量 : 475.616
MDL号 : MFCD00077863
存储条件:

粉末 Inert atmosphere,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(220.77 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 100 mg/mL(210.25 mM)

动物实验配方:
生物活性
描述 Dinoprost tromethamine salt, also known as Prostaglandin F2α tromethamine salt, is a potent agonist of the prostaglandin F (PGF) receptor (FP receptor) that can be administered orally. It acts as a luteolytic hormone primarily synthesized in the endometrial luminal epithelium and corpus luteum (CL). Dinoprost tromethamine salt plays a pivotal role in initiating and advancing labor [1][2].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02052908 Lynch Syndrome Phase 1 Active, not recruiting - United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 收起 <<
NCT01974674 Patients With Type 1 Diabetes Phase 2 Recruiting January 2022 France ... 展开 >> Saint Louis hospital Recruiting Paris, Ile de France, France, 75010 Contact: Pierre CATTAN, MD PhD    33 1 42494786    pierre.cattan@sls.aphp.fr 收起 <<
NCT01688154 Triglyceride Metabolism ... 展开 >> Cardiovascular Function 收起 << Not Applicable Completed - Spain ... 展开 >> CTNS Reus, Tarragona, Spain, 43204 Technological Center of Nutrition and Health (CTNS) Reus, Tarragona, Spain, 43204 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.10mL

0.42mL

0.21mL

10.51mL

2.10mL

1.05mL

21.03mL

4.21mL

2.10mL

参考文献

[1]Hagen Thieme, et al. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci. 2006 Mar;47(3):938-45.

[2]Xin Wen, et al. Prostaglandin F2α Induces Goat Corpus Luteum Regression via Endoplasmic Reticulum Stress and Autophagy. Front Physiol. 2020 Sep 11;11:868.